LMX4

Dosage form: cream
Ingredients: LIDOCAINE 40mg in 1g
Labeler: Ferndale Laboratories, Inc.
NDC code: 0496-0882

Medically reviewed by Drugs.com. Last updated on May 5, 2025.

L.M.X.4

Active ingredient

Lidocaine 4% w/w

Purpose

Topical anesthetic

Uses

temporarily relieves pain and itching due to

minor cuts
minor scrapes
minor burns
sunburn
minor skin irritations
insect bites

Warnings

For external use only.

Do not use

in or near the eyes
in large quantities, particularly over raw surfaces or blistered areas

Stop use and ask a doctor if:

allergic reaction occurs
condition worsens or does not improve within 7 days
symptoms clear up and return within a few days
redness, irritation, swelling, pain or other symptoms begin or increase

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Adults and children 2 years and older: Apply externally to the affected area up to 3 to 4 times a day
Children under 2 years: Consult a doctor

Other Information

May be applied under occlusive dressing.
Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].

Inactive ingredients

benzyl alcohol, carbomer 940, cholesterol, hydrogenated lecithin, polysorbate 80, propylene glycol, trolamine, vitamin E acetate, water

Package Labels-Principal Display Panels

Manufactured by Ferndale Laboratories, Inc.

Ferndale, MI 48220 U.S.A.

Toll free (888) 548-0900

www.ferndalelabs.com

L.M.X.4® is a registered trademark of Ferndale IP, Inc.

Tegaderm™ is a trademark of 3M Corporation.

NDC 0496-0882-06 L.M.X.4® 5 x 5 grams

NDC 0496-0882-07 L.M.X.4® 5 x 5 grams with 10 3M Tegaderm™ Transparent Dressings

NDC 0496-0882-15 L.M.X.4® 15 grams

NDC 0496-0882-30 L.M.X.4® 30 grams

NDC 0496-0882-71 L.M.X.4® 30 grams with 10 3M Tegaderm™ Transparent Dressings

NDC 0496-0882-05 L.M.X.4 5 grams

LMX4
lidocaine cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:0496-0882
Route of Administration	TOPICAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LIDOCAINE (LIDOCAINE)	LIDOCAINE	40 mg in 1 g

Inactive Ingredients
Ingredient Name	Strength
BENZYL ALCOHOL
CARBOMER HOMOPOLYMER TYPE C
CHOLESTEROL
POLYSORBATE 80
PROPYLENE GLYCOL
TROLAMINE
ALPHA-TOCOPHEROL ACETATE
WATER

Packaging
#	Item Code	Package Description
1	NDC:0496-0882-06	5 TUBE in 1 CARTON
1	NDC:0496-0882-05	5 g in 1 TUBE
2	NDC:0496-0882-07	5 TUBE in 1 BOX
2	NDC:0496-0882-05	5 g in 1 TUBE
3	NDC:0496-0882-15	15 g in 1 TUBE
4	NDC:0496-0882-30	30 g in 1 TUBE
5	NDC:0496-0882-05	5 g in 1 TUBE
6	NDC:0496-0882-71	1 TUBE in 1 BOX
6	NDC:0496-0882-30	30 g in 1 TUBE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part348	01/03/2011

Labeler - Ferndale Laboratories, Inc. (005320536)

Establishment
Name	Address	ID/FEI	Operations
Ferndale Laboratories, Inc.		005320536	manufacture(0496-0882)

Revised: 05/2020

Document Id: a58a2e97-9b55-3b5a-e053-2995a90acb5a

Set id: f0e7c92f-8b0b-4045-b659-af9f6e81260f

Version: 4

Effective Time: 20200513

Ferndale Laboratories, Inc.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer